A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study
Completed · Phase 2 · Has a placebo group
Conditions studied: Sarcopenia
In brief
This extension study was a 24-week off-drug follow-up of the core CBYM338E2202 (NCT ) study and the main objective was to determine the long-term durability of bimagrumab (BYM338) effect after a 6-month treatment period.
Key facts
- Study ID
- NCT02468674
- Run by
- Novartis Pharmaceuticals
- People needed
- 160
- Starts
- 2015-07-22
- Expected to finish
- 2018-12-03
- Last updated by the study team
- 2020-06-16
Who can join
Age: 70 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Miami Lakes, Florida, United States
- Novartis Investigative Site — Gainesville, Georgia, United States
- Novartis Investigative Site — Spartanburg, South Carolina, United States
- Novartis Investigative Site — San Antonio, Texas, United States
- Novartis Investigative Site — Madison, Wisconsin, United States
- Novartis Investigative Site — St Albans, Victoria, Australia
- Novartis Investigative Site — Brussels, Belgium
- Novartis Investigative Site — Prague, Czechia
- Novartis Investigative Site — Copenhagen NV, Denmark
- Novartis Investigative Site — Montpellier, France
- Novartis Investigative Site — Pessac, France
- Novartis Investigative Site — Ōbu, Aichi-ken, Japan
- Novartis Investigative Site — Toyohashi, Aichi-ken, Japan
- Novartis Investigative Site — Mizunami, Gifu, Japan
- Novartis Investigative Site — Nara, Nara, Japan
- Novartis Investigative Site — Kawachi-Nagano, Osaka, Japan
- Novartis Investigative Site — Kitaadachigun Inamachi, Saitama, Japan
- Novartis Investigative Site — Kitamoto, Saitama, Japan
- Novartis Investigative Site — Itabashi Ku, Tokyo, Japan
- Novartis Investigative Site — Kiyose, Tokyo, Japan
- Novartis Investigative Site — Koto-ku, Tokyo, Japan
- Novartis Investigative Site — Moscow, Russia
- Novartis Investigative Site — Moscow, Russia
- Novartis Investigative Site — Saint Petersburg, Russia
- Novartis Investigative Site — Yaroslavl, Russia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.